Tweet from EricTopol at November 15, 2022 at 11:56AM
Our prospective Paxlovid rebound study with controls preprint is posted
By symptoms: ~12% rebound (19% Pax vs 7% controls)
By positive testing: ~5% rebound (14% Pax vs 9% controls)
Much lower than many estimates
https://t.co/czeGEYIJvA by @JayPandit @michaelmina_lab @ScrippsRTI— Eric Topol (@EricTopol)
Nov 15, 2022
from http://twitter.com/EricTopol